Money, Fiance News, Press Release Distribution
Financial News and Press Release Distribution Services

Submit RSS Feed | About US | Contact Us

Home | Personal Finance News | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

Money News Media
Finacial Times
FOX Business

Money News Now

Reuters Money
RSS News Feed
Get your news feed listed here as other news media shown above! Submit RSS News Feed

Personal Finance News Releases

China Vaccine Market is projected to cross USD 9 Billion mark by the end of the year 2025

(MoneyNewsWire.Net, April 14, 2020 ) China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type, Products, "Company”

The China Vaccine Market is projected to cross USD 9 Billion mark by the end of the year 2025. The significant factors that are propelling the market growth are; rising awareness among people, growing research, and development expenditure in the vaccine sector, improving healthcare infrastructure in China, rising per capita income.

The government of China withdraws the one-child policy in the year 2017. Therefore an increasing number of newborn babies reached 16.7 Million in the year 2018, and again this number is expected to grow in the coming future. China is one of the world's biggest vaccine manufacturers. So, higher demand and proper supply of vaccines will further boost the China vaccine market during the forecast period.

Chinese people are quite aware of immunization, and private companies have invested a massive chunk of money in sustaining the market growth of China Vaccine market in the long run. In the past few years, China's vaccine market has faced several scandals, which may restrain the growth of the vaccine market.

To promote the broader uses of the vaccines, the Chinese government is facilitating vaccines at low cost or even giving it free in government hospitals. They are also increasing private centers that can promote vaccine services based on customer demand.

China Vaccine Market Analysis by Disease Type

In this section of the report, we have done China vaccine market analysis by disease type. Meningococcal meningitis, Pneumococcal, and DTP Vaccine are the first vaccine dominating the overall China vaccine market and anticipated to capture the largest share in the vaccine market. Based on the disease type vaccine market of China is divided into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.

Request a free Brochure copy of the report:

China Vaccine Market Analysis by Products

Based on the product, the China vaccine market is fragmented into seven parts; MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2, and Men A, PCV13, and PPV23. PCV13 vaccine product gained the largest market share in the overall market. It is anticipated that PCV13 continues to hold the leading market position during the forecast period.

China Vaccine Market Analysis by Public and Private Vaccine

This section of the report provides a detailed analysis of the Public and Private Vaccine market along with several government initiatives and private expenditure on R&D process.

Company Analysis Covered in the Report

In this section of the report, we have done an overall analysis of leading key players such as business overview, sales analysis, and recent development and strategy of the below mentioned 6 countries.

1. Sinopharm Group (China National Biotec Group Company Limited)

2. Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd

3. Chongqing Zhifei Biological Products Co Ltd

4. Hualan Biological Engineering Inc

5. Liaoning Chengda Co Ltd

6. Walvax Biotechnology Co Ltd

China Vaccine Market@

Key Topics Covered :

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

4.3 Opportunities

5. China Vaccine Market

5.1 Public

5.2 Private

6. China Vaccine Doses

6.1 Public

6.2 Private

7. Market Share – China Vaccine Analysis

7.1 By Sectors

7.2 By Vaccine Doses Share

7.3 By Products Type

7.4 By Disease Type

8. Meningococcal Meningitis Vaccine

8.1 Market

8.2 Vaccine Doses

8.3 Vaccine Pipeline

9. Pneumococcal Vaccines

9.1 Market

9.2 Doses

9.3 Vaccine Pipeline

10. DTP Vaccine

10.1 Market – DTP Vaccine

10.2 Doses – DTP Vaccine

10.3 Vaccine Pipeline

11. Rabies Vaccine Market

12. Ebola Vaccine

12.1 Market

12.2 Vaccine Pipeline

13. Products Type - China Vaccine Market

13.1 MCV4

13.2 MPSV4

13.3 MCV2-Hib

13.4 MCV2

13.5 MPSV2 and Men A

13.6 PCV13

13.7 PPV23

14. Vaccine Regulatory Authority of China

15. Required and Recommended Vaccinations for China Travel

16. Mergers and Acquisitions

17. Company Analysis

17.1 Sinopharm Group (China National Biotec Group Company Limited)

17.2 Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd

17.3 Chongqing Zhifei Biological Products Co Ltd

17.4 Hualan Biological Engineering Inc.

17.5 Liaoning Chengda Co. Ltd.

17.6 Walvax Biotechnology Co. Ltd.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Adult Vaccine Market@

Pediatric Vaccine Market@

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research

Phone: +1-678-302-0700



Follow us on LinkedIn:

Renub Research

Rajat Gupta

Market Research, Bus

Source: EmailWire.Com

Personal Finance News
  • Auto
  • CDs
  • College
  • Credit Cards
  • Insurance
  • Mortgage
  • Mutual Funds
  • Retirement
  • Savings
  • Taxes

  • Money RSS Marketpalce

    Free Finance Magazines Downloads
    Get free publications including magazines, white papers on finance, investments.
    Submit RSS news feed on Finance, Investment.
    Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.

    Money NewsWire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    Money-NewsWire.Net - Newswire and Press Release service of GroupWeb Media LLC